Intravenous pantoprazole rapidly controls gastric acid hypersecretion in patients with Zollinger-Ellison syndrome. (Q41726700)

PubMed publication ID

10734021

8 October 2017

title

Intravenous pantoprazole rapidly controls gastric acid hypersecretion in patients with Zollinger-Ellison syndrome (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6736552&resulttype=core&format=json

12 May 2020

author name string

E A Lew

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6736552&resulttype=core&format=json

12 May 2020

J R Pisegna

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6736552&resulttype=core&format=json

12 May 2020

J A Starr

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6736552&resulttype=core&format=json

12 May 2020

E F Soffer

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6736552&resulttype=core&format=json

12 May 2020

C Forsmark

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6736552&resulttype=core&format=json

12 May 2020

I M Modlin

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6736552&resulttype=core&format=json

12 May 2020

J H Walsh

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6736552&resulttype=core&format=json

12 May 2020

M Beg

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6736552&resulttype=core&format=json

12 May 2020

W Bochenek

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6736552&resulttype=core&format=json

12 May 2020

D C Metz

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6736552&resulttype=core&format=json

12 May 2020

language of work or name

English

0 references

publication date

1 April 2000

1 reference

PubMed publication ID

8 October 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6736552&resulttype=core&format=json

12 May 2020

volume

118

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6736552&resulttype=core&format=json

12 May 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6736552&resulttype=core&format=json

12 May 2020

page(s)

696-704

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6736552&resulttype=core&format=json

Primary peptic ulcerations of the jejunum associated with islet cell tumors of the pancreas

12 May 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970139-9

Thirty years' experience with gastrinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970139-9

Use of omeprazole in Zollinger-Ellison syndrome: a prospective nine-year study of efficacy and safety.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970139-9

Substituted benzimidazoles inhibit gastric acid secretion by blocking (H+ + K+) ATPase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970139-9

Currently used doses of omeprazole in Zollinger-Ellison syndrome are too high

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970139-9

Structural aspects of the gastric H,K ATPase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970139-9

Pharmacological aspects of acid secretion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970139-9

PACAP type I receptor activation regulates ECL cells and gastric acid secretion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970139-9

Determinants of metastatic rate and survival in patients with Zollinger-Ellison syndrome: a prospective long-term study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970139-9

Parenteral control of gastric acid hypersecretion in patients with Zollinger-Ellison syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970139-9

Zollinger-Ellison syndrome. Recognition and management of acid hypersecretion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970139-9

Intravenous omeprazole in patients with Zollinger-Ellison syndrome undergoing surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970139-9

Control of acute Zollinger-Ellison syndrome with intravenous omeprazole

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970139-9

(H+, K+)-ATPase inhibiting 2-[(2-pyridylmethyl)sulfinyl]benzimidazoles. 4. A novel series of dimethoxypyridyl-substituted inhibitors with enhanced selectivity. The selection of pantoprazole as a clinical candidate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970139-9

Single intravenous administration of the H+, K(+)-ATPase inhibitor BY 1023/SK&F 96022--inhibition of pentagastrin-stimulated gastric acid secretion and pharmacokinetics in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970139-9

Inhibition of pentagastrin-induced gastric acid secretion by intravenous pantoprazole: a dose-response study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970139-9

Lack of pharmacokinetic interaction of pantoprazole with diazepam in man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970139-9

Studies of Various Administration Methods for Lansoprazole Injection Using 24-Hour Intragastric pH Monitoring

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970139-9

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970139-9

Medical management of patients with Zollinger-Ellison syndrome who have had previous gastric surgery: a prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970139-9

Use of omeprazole in patients with Zollinger-Ellison syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970139-9

Equipotent inhibition of gastric acid secretion by equal doses of oral or intravenous pantoprazole

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970139-9

Prospective study of efficacy and safety of lansoprazole in Zollinger-Ellison syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970139-9

Effect of single and repeated intravenous doses of omeprazole on pentagastrin stimulated gastric acid secretion and pharmacokinetics in man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970139-9

Pharmacokinetics of oral and intravenous omeprazole in patients with the Zollinger-Ellison syndrome

7 January 2021

1 reference

12 December 2020

Omeprazole: effective, convenient therapy for Zollinger-Ellison syndrome

1 reference

12 December 2020

Control of gastric acid hypersecretion in the management of patients with Zollinger-Ellison syndrome.

1 reference

12 December 2020

Pharmacokinetics of pantoprazole in man.

1 reference

12 December 2020

Proton pump inhibitors and acid-related diseases

1 reference

12 December 2020

Ocular damage associated with proton pump inhibitors

1 reference

12 December 2020

Omeprazole (correction of omepraxole) and ocular damage. Lack of causality holds true

1 reference

12 December 2020

10.1016/S0016-5085(00)70139-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6736552&resulttype=core&format=json

12 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6736552&resulttype=core&format=json

12 May 2020

PubMed publication ID

10734021

1 reference